Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling

Ryo Fukuyama1, Takashi Fujita, Yasutaka Azuma

  • 1Department of Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata 573-0101, Japan.

Insights

Statins inhibit osteoblast migration by blocking Rac-Akt signaling. This research clarifies how these bone-building drugs affect cell movement during skeletal repair.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Cell migration is crucial for skeletal tissue repair and remodeling.
  • The precise mechanisms governing osteoblast migration are not fully understood.
  • Statins are known to enhance bone density, but their impact on osteoblast migration requires elucidation.

Purpose of the Study:

  • To investigate the effects of fluvastatin and mevastatin on platelet-derived growth factor (PDGF)-induced osteoblast migration.
  • To elucidate the role of Rac-Akt signaling in PDGF-induced osteoblast migration.
  • To determine how statins modulate osteoblast migration via specific signaling pathways.

Main Methods:

  • Utilized MC3T3-E1 osteoblastic cells for migration assays.
  • Administered PDGF to stimulate cell migration.
  • Applied fluvastatin and mevastatin, along with mevalonate, geranylgeranylpyrophosphate, and farnesylpyrophosphate, to assess their effects.
  • Employed dominant-negative Rac and Akt constructs to probe signaling pathways.

Main Results:

  • PDGF significantly promoted osteoblast migration.
  • Fluvastatin and mevastatin inhibited PDGF-induced osteoblast migration.
  • Mevalonate and geranylgeranylpyrophosphate, but not farnesylpyrophosphate, reversed the statin-mediated inhibition.
  • Dominant-negative Rac impaired PDGF-induced migration and reduced Akt phosphorylation.
  • Fluvastatin decreased Akt phosphorylation, and dominant-negative Akt inhibited PDGF-induced migration.

Conclusions:

  • Statins inhibit PDGF-induced osteoblast migration.
  • Rac-Akt signaling is a critical pathway in osteoblast migration.
  • Statins likely restrain Rac function by inhibiting geranylgeranylation, subsequently reducing Akt activation and osteoblast migration.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
Role of Myosin in Cell Migration01:18

Role of Myosin in Cell Migration

Myosins are multimeric motor proteins involved in various cellular processes such as migration, adhesion, and proliferation. Myosin II is the most common type in animal cells, which binds and cross-links actin filaments.
Myosin II  is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction. It is...